Related Experiment Video
Updated: Apr 19, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
MDM2-p53 pathway in hepatocellular carcinoma
Xuan Meng1, Derek A Franklin2, Jiahong Dong3
1Department of Radiation Oncology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Hospital and Institute of Hepatobiliary Surgery, Chinese PLA General Hospital, Beijing, China. Laboratory of Biological Cancer Therapy, Xuzhou Medical College, Xuzhou, China.
Alterations in the TP53 gene and MDM2 overexpression are common in cancers, particularly hepatocellular carcinoma (HCC). Understanding the MDM2-p53 feedback loop offers potential for improved cancer diagnostics, prognostics, and therapeutics.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The TP53 gene and its regulator MDM2 are frequently altered in various cancers.
- The MDM2-p53 feedback loop is crucial in tumor progression.
- Hepatocellular carcinoma (HCC) treatments remain less effective compared to other cancers.
Purpose of the Study:
- To review current research on the MDM2-p53 pathway in cancer, with a specific focus on HCC.
- To discuss the implications of p53 mutations and MDM2 alterations in HCC.
- To explore the diagnostic, prognostic, and therapeutic potential of targeting the MDM2-p53 pathway.
Main Methods:
- Literature review of studies on the MDM2-p53 pathway in cancer.
- Focus on research pertaining to hepatocellular carcinoma.
- Analysis of p53 mutations and MDM2 alterations in HCC.
Main Results:
- Abnormalities in TP53 and MDM2 overexpression are prevalent in cancers, including HCC.
- The MDM2-p53 feedback loop significantly impacts tumor progression.
- Targeting this pathway presents potential clinical benefits.
Conclusions:
- The MDM2-p53 pathway is a critical area for cancer research, especially in HCC.
- Understanding alterations in this pathway can lead to novel diagnostic and prognostic markers.
- Therapeutic strategies targeting the MDM2-p53 axis show promise for cancer treatment.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway

